Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi ‐institutional study

ConclusionPatients with sinonasal malignancy have a much lower rate of symptomatology during tumor recurrence than that observed in head and neck cancer overall. Furthermore, time to recurrence is substantially longer, as a majority of head and neck cancer recurrences occur in the first 12 months after treatment. These differences highlight the need for more tailored surveillance paradigms in asymptomatic patients with a history of a definitively treated sinonasal neoplasm.

Source: International Forum of Allergy and Rhinology - February 15, 2019 Category: Allergy & Immunology Authors: Alan D. Workman, Nathalia Velasquez, Nayel I. Khan, Nicole A. Borchard, Edward C. Kuan, James N. Palmer, Eric W. Wang, Zara M. Patel, Nithin D. Adappa Tags: ORIGINAL ARTICLE Source Type: research